People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lenz Therapeutics, Inc. | — | Biotechnology | Series C | $136.2M | $1.2B | 2023 |
| Turnstone Biologics Corp. | — | Biotechnology | Series C | $122.1M | $2.2B | 2019 |
| Tornado Medical Systems, Inc. | — | Biotechnology | Series A | $14.7M | $105.8M | 2013 |
| ClearMRI Solutions Ltd. | — | Other Technology | Seed | $1.2M | $40.7M | 2013 |
Stefan Larson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stefan Larson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian McDonald | 2 | 6 |
| Jae Kim | 2 | 2 |
| Jerel Davis | 1 | 13 |
| Rishi Gupta | 1 | 12 |
| Clare Ozawa | 1 | 8 |
| Mark - Lester | 1 | 6 |
| Zach Scheiner | 1 | 6 |
| Patrick Machado | 1 | 3 |
| Robert Gould | 1 | 3 |
| James McCollum | 1 | 3 |
| Jeff Courtney | 1 | 3 |
| CHRIS DIMITROPOULOS | 1 | 3 |
| Jane Henderson | 1 | 2 |
| Brad Bolzon | 1 | 2 |
| Frederic Guerard | 1 | 2 |
| Sammy Farah | 1 | 2 |
| William O'Reilly | 1 | 2 |
| Evert Schimmelpennink | 1 | 2 |
| Arsen R. Hajian | 1 | 1 |
| GERALD HORN | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.